Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 1
1958 1
1959 1
1960 4
1961 6
1962 5
1963 4
1964 6
1965 10
1966 6
1967 6
1968 12
1969 7
1970 10
1971 15
1972 5
1973 13
1974 12
1975 13
1976 14
1977 16
1978 11
1979 8
1980 17
1981 16
1982 13
1983 17
1984 11
1985 17
1986 6
1987 17
1988 26
1989 20
1990 18
1991 24
1992 23
1993 22
1994 25
1995 34
1996 44
1997 48
1998 32
1999 40
2000 52
2001 44
2002 52
2003 44
2004 32
2005 39
2006 30
2007 46
2008 59
2009 39
2010 71
2011 69
2012 65
2013 74
2014 73
2015 96
2016 99
2017 96
2018 79
2019 87
2020 120
2021 106
2022 86
2023 87
2024 100

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,212 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic nutritional index is an independent risk factor for continuing S-1 adjuvant chemotherapy in patients with pancreatic cancer who received neoadjuvant chemotherapy and surgical resection.
Kawahara S, Aoyama T, Murakawa M, Kanemoto R, Takahashi D, Kamioka Y, Hashimoto I, Maezawa Y, Kobayashi S, Ueno M, Yamamoto N, Oshima T, Yukawa N, Rino Y, Saito A, Morinaga S. Kawahara S, et al. Among authors: oshima t. BMC Cancer. 2024 Nov 29;24(1):1469. doi: 10.1186/s12885-024-13244-z. BMC Cancer. 2024. PMID: 39609741 Free PMC article.
Phase 1b/2 study of the liposomal formulation of eribulin (E7389-LF) in combination with nivolumab: Results from the phase 2 esophageal cancer cohort.
Oshima T, Yamamoto S, Kawakami H, Makino T, Kawazoe A, Masuishi T, Tsushima T, Hirao M, Tsuda M, Hino K, Yamamoto N, Hara H, Kaname S, Matsuoka D, Otake Y, Yasuda K, Takase T, Takashima S, Semba T, Ooki A. Oshima T, et al. BJC Rep. 2024 Sep 4;2(1):66. doi: 10.1038/s44276-024-00066-6. BJC Rep. 2024. PMID: 39516370 Free PMC article.
Impact of Nutritional Therapy during Intensive Care Unit Admission on Post-Intensive Care Syndrome in Patients with COVID-19.
Suganuma S, Nakamura K, Kato H, Hemmi M, Kawabata K, Hosozawa M, Muto Y, Hori M, Iba A, Asahi T, Kawauchi A, Fujitani S, Hatakeyama J, Oshima T, Ota K, Kamijo H, Iso H. Suganuma S, et al. Among authors: oshima t. Ann Nutr Metab. 2024 Nov 4:1-10. doi: 10.1159/000542298. Online ahead of print. Ann Nutr Metab. 2024. PMID: 39496239 Free article.
Biomarker Study for Selecting Neoadjuvant Chemotherapy Regimens Based on Prognostic Prediction Using Gastric Cancer Biopsy Specimens from a Phase II Randomized Controlled Trial.
Oshima T, Yoshikawa T, Miyagi Y, Morita S, Yamamoto M, Tanabe K, Nishikawa K, Ito Y, Matsui T, Kimura Y, Aoyama T, Ogata T, Cho H, Tsuburaya A, Sakamoto J. Oshima T, et al. Anticancer Res. 2024 Nov;44(11):4951-4960. doi: 10.21873/anticanres.17320. Anticancer Res. 2024. PMID: 39477312 Clinical Trial.
Clinical usefulness of C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker in patients undergoing surgical resection of pancreatic cancer.
Kawahara S, Aoyama T, Murakawa M, Kanemoto R, Matsushita N, Hashimoto I, Kamiya M, Maezawa Y, Kobayashi S, Ueno M, Yamamoto N, Oshima T, Yukawa N, Saito A, Morinaga S. Kawahara S, et al. Among authors: oshima t. Langenbecks Arch Surg. 2024 Oct 21;409(1):317. doi: 10.1007/s00423-024-03512-8. Langenbecks Arch Surg. 2024. PMID: 39432010
2,212 results